MY
Manisha Yogesh Agrawal
About Manisha Yogesh Agrawal
Data last updated:
Manisha Yogesh Agrawal is a Director at Ganga Builders Private Limited (since 2011), Designated Partner at Anvaxx Laboratories Llp (since 2016) and Director at Averon Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Real Estate and Construction, Business Services and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹61,215; the largest is Ganga Builders Private Limited at ₹58,543 (FY 2024). Earlier, Manisha Yogesh Agrawal was a Director at Riteaid Finance Private Limited (2018–2025) and Director at Axera Enterprises Private Limited (2018–2025) and 40 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ganga Builders Private Limited U70100MH1988PTC049589 | Director | 31 Jan 2011 | 1988 | ₹58,543 (FY 2024) | Active |
| Anvaxx Laboratories Llp AAG-5427 | Designated Partner | 01 Jun 2016 | 2016 | ₹2,672 (FY 2026) | Active |
| Averon Private Limited U70200MH2025PTC462999 | Director | 15 Dec 2025 | 2025 | Active | |
| Valenta Enterprises Llp ACT-2299 | Designated Partner | 05 Dec 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Riteaid Finance Private Limited U65999MH2017PTC301115 | Director | 01 Feb 2018 | 2017 | ₹22,510 (FY 2022) | Under Process Of Striking Off |
| Axera Enterprises Private Limited U74999MH2018PTC306226 | Director | 09 Mar 2018 | 2018 | Active | |
| Vetrium Health Private Limited U24232MH2007PTC167751 | Director | 14 Jan 2011 | 2007 | Converted To Llp | |
| Almiron Pharma Private Limited U24230MH2008PTC178444 | Director | 14 Jan 2011 | 2008 | Converted To Llp | |
| Aureus Pharma Private Limited U51909MH2007PTC171003 | Director | 14 Jan 2011 | 2007 | Converted To Llp | |
| Kwera Lands Private Limited U45200MH2007PTC168448 | Director | 31 Jan 2011 | 2007 | ₹16,890 (FY 2017) | Active |
| Vyata Space Concepts Private Limited U24230MH2005PTC153977 | Director | 31 Jan 2011 | 2005 | ₹10,562 (FY 2017) | Active |
 Cdc Pharma Private Limited U24230MH2005PTC154325 | Director | 14 Jan 2011 | 2005 | Converted To Llp | |
| Nuventa Enterprises Llp AAL-4745 | Designated Partner | 24 Oct 2019 | 2017 | Strike Off | |
| Nuventa Pharma Llp AAG-4954 | Designated Partner | 28 May 2016 | 2016 | Strike Off | |
| Aureus Pharma Llp AAG-4962 | Designated Partner | 28 May 2016 | 2016 | Strike Off | |
| Avecia Pharma Llp AAG-4960 | Designated Partner | 28 May 2016 | 2016 | Strike Off | |
| Cdc Pharma Llp AAG-4957 | Designated Partner | 28 May 2016 | 2016 | Strike Off | |
| Axera Pharma Llp AAG-5423 | Designated Partner | 01 Jun 2016 | 2016 | Strike Off | |
| Renamax Labs Llp AAG-5424 | Designated Partner | 01 Jun 2016 | 2016 | Strike Off | |
| Zillion Labs Llp AAG-5421 | Designated Partner | 01 Jun 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manisha Yogesh Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aayush Madhusudan Agrawal | 03129764 | Ganga Builders Private Limited , Anvaxx Laboratories Llp | Director |
| Richa Ravi Agrawal | 00075827 | Ganga Builders Private Limited , Anvaxx Laboratories Llp | Director |
| Smriti Rajesh Agrawal | 00075064 | Anvaxx Laboratories Llp | Designated Partner |
| Yogesh Mannalal Agrawal | 00073673 | Averon Private Limited , Valenta Enterprises Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manisha Yogesh Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manisha Yogesh Agrawal
Manisha Yogesh Agrawal currently holds 4 directorships: Ganga Builders Private Limited (Director, since 31 Jan 2011, revenue ₹58,543 (FY 2024)); Anvaxx Laboratories Llp (Designated Partner, since 01 Jun 2016, revenue ₹2,672 (FY 2026)); Averon Private Limited (Director, since 15 Dec 2025); Valenta Enterprises Llp (Designated Partner, since 05 Dec 2025).
Manisha Yogesh Agrawal was first appointed on 01 May 2000 as Director at Gabs Investments Private Limited. The most recent appointment on record is 15 Dec 2025 at Averon Private Limited.
The 2 current companies of Manisha Yogesh Agrawal that report revenue have a combined latest revenue of ₹61,215: Ganga Builders Private Limited ₹58,543 (FY 2024); Anvaxx Laboratories Llp ₹2,672 (FY 2026).
Manisha Yogesh Agrawal held 42 earlier board appointments: Riteaid Finance Private Limited (Director, 01 Feb 2018 to 30 Sep 2025); Axera Enterprises Private Limited (Director, 09 Mar 2018 to 30 Sep 2025); Vetrium Health Private Limited (Director, 14 Jan 2011 to 18 Dec 2013); Almiron Pharma Private Limited (Director, 14 Jan 2011 to 18 Dec 2013); Aureus Pharma Private Limited (Director, 14 Jan 2011 to 18 Dec 2013); and 37 more.
The current boards of Manisha Yogesh Agrawal's companies include Aayush Madhusudan Agrawal (Ganga Builders Private Limited), Richa Ravi Agrawal (Ganga Builders Private Limited), Smriti Rajesh Agrawal (Anvaxx Laboratories Llp), Yogesh Mannalal Agrawal (Averon Private Limited).